These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17034954)

  • 1. Oral progesterone decreases saccadic eye velocity and increases sedation in women.
    van Broekhoven F; Bäckström T; Verkes RJ
    Psychoneuroendocrinology; 2006 Nov; 31(10):1190-9. PubMed ID: 17034954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women.
    Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of allopregnanolone on sedation in men, and in women on oral contraceptives.
    van Broekhoven F; Bäckström T; van Luijtelaar G; Buitelaar JK; Smits P; Verkes RJ
    Psychoneuroendocrinology; 2007 Jun; 32(5):555-64. PubMed ID: 17470385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone.
    Andréen L; Spigset O; Andersson A; Nyberg S; Bäckström T
    Maturitas; 2006 Jun; 54(3):238-44. PubMed ID: 16406399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoallopregnanolone antagonize allopregnanolone-induced effects on saccadic eye velocity and self-reported sedation in humans.
    Bengtsson SK; Nyberg S; Hedström H; Zingmark E; Jonsson B; Bäckström T; Bixo M
    Psychoneuroendocrinology; 2015 Feb; 52():22-31. PubMed ID: 25459890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
    Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and behavioral effects of allopregnanolone in healthy women.
    Timby E; Balgård M; Nyberg S; Spigset O; Andersson A; Porankiewicz-Asplund J; Purdy RH; Zhu D; Bäckström T; Poromaa IS
    Psychopharmacology (Berl); 2006 Jun; 186(3):414-24. PubMed ID: 16177884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone.
    Klatzkin RR; Morrow AL; Light KC; Pedersen CA; Girdler SS
    Psychoneuroendocrinology; 2006 Nov; 31(10):1208-19. PubMed ID: 17046166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls.
    Kask K; Bäckström T; Lundgren P; Sundström Poromaa I
    Pharmacol Biochem Behav; 2009 Jun; 92(4):608-13. PubMed ID: 19268499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
    Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
    Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of progesterone produces mild sedative-like effects in men and women.
    Söderpalm AH; Lindsey S; Purdy RH; Hauger R; Wit de H
    Psychoneuroendocrinology; 2004 Apr; 29(3):339-54. PubMed ID: 14644065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
    Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopregnanolone serum concentrations and neurosteroid sensitivity during withdrawal from postmenopausal hormone therapy.
    Wihlbäck AC; Nyberg S; Andersson A; Bixo M; Bäckström T; Sundström-Poromaa I
    Gynecol Endocrinol; 2007 Oct; 23(10):590-6. PubMed ID: 17852417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women.
    Hedström H; Bixo M; Nyberg S; Spigset O; Zingmark E; Bäckström T
    Psychopharmacology (Berl); 2009 Mar; 203(1):85-98. PubMed ID: 18949461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers.
    Freeman EW; Purdy RH; Coutifaris C; Rickels K; Paul SM
    Neuroendocrinology; 1993 Oct; 58(4):478-84. PubMed ID: 7904330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
    de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
    J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone selectively increases amygdala reactivity in women.
    van Wingen GA; van Broekhoven F; Verkes RJ; Petersson KM; Bäckström T; Buitelaar JK; Fernández G
    Mol Psychiatry; 2008 Mar; 13(3):325-33. PubMed ID: 17579609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GR3027 reversal of neurosteroid-induced, GABA-A receptor-mediated inhibition of human brain function: an allopregnanolone challenge study.
    Johansson M; Månsson M; Lins LE; Scharschmidt B; Doverskog M; Bäckström T
    Psychopharmacology (Berl); 2018 May; 235(5):1533-1543. PubMed ID: 29492615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects.
    Sundström I; Andersson A; Nyberg S; Ashbrook D; Purdy RH; Bäckström T
    Neuroendocrinology; 1998 Feb; 67(2):126-38. PubMed ID: 9508043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
    de Haas SL; de Visser SJ; van der Post JP; Schoemaker RC; van Dyck K; Murphy MG; de Smet M; Vessey LK; Ramakrishnan R; Xue L; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Jan; 22(1):24-32. PubMed ID: 18187530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.